Therapy Areas: Vaccines
Bavarian Nordic reports purchases under share buy-back programme
22 September 2026 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) on Monday published an update on its share buy-back programme launched on 1 September 2026, under which the company wi...
VaxThera partners with Codagenix for next generation yellow fever vaccine advancement
16 September 2026 - Colombian biotechnology company VaxThera S.A.S. and US-based Codagenix Inc, a clinical-stage biotechnology company focused on synthetic biology-based vaccines, announced on Tuesday...
PSMA Connect partners with HealthIQ Solutions
15 September 2026 - PSMA Connect, a Healthcare Group Purchasing Organisation (GPO), and HealthIQ Solutions, a provider of remote patient care management and clinical technology, said on Monday that th...
ABEC opens new manufacturing facility in Wilson, NC
11 September 2026 - ABEC, a provider of customised solutions and services for biopharmaceutical manufacturing, on Thursday announced the grand opening of its newest manufacturing facility in Wilson, N...
4basebio announces expansion of DNA offering for personalised mRNA medicines
7 September 2026 - Synthetic DNA 4basebio PLC (AIM: 4BB) declared on Monday that it has expanded its DNA offering to support production of critical starting material for personalised mRNA medicines.Th...
Clover Biopharmaceuticals reports positive Phase 2 trial data for respiratory combination vaccine candidates
7 September 2026 - Chinese biotechnology company Clover Biopharmaceuticals Ltd (HKEX:02197) announced on Sunday positive preliminary data from a Phase 2 clinical trial in older adults in Australia eva...